Integrated analysis of the clinical consequence and associated gene expression of ALK in ALK-positive human cancers.
Integrated analysis of the clinical consequence and associated gene expression of ALK in ALK-positive human cancers.
复制标题
ALK阳性人类癌症中ALK的临床后果和相关基因表达的综合分析。
DOI:
10.1016/j.heliyon.2022.e09878
复制
发表时间:
2022-07
期刊:
影响因子:
4
通讯作者:
Tsukahara, Toshifumi
中科院分区:
文献类型:
--
作者:
Saifullah;Tsukahara, Toshifumi
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that is genetically altered in several cancers, including NSCLC, melanoma, lymphoma, and other tumors. Although ALK is associated with various cancers, the relationship between ALK expression and patient prognosis in different cancers is poorly understood. Here, using multidimensional approaches, we revealed the correlation between ALK expression and the clinical outcomes of patients with LUAD, melanoma, OV, DLBC, AML, and BC. We analyzed ALK transcriptional expression, patient survival rate, genetic alteration, protein network, and gene and microRNA (miRNA) co-expression. Compared to that in normal tissues, higher ALK expression was found in LUAD, melanoma, and OV, which are associated with poor patient survival rates. In contrast, lower transcriptional expression was found to decrease the survival rate of patients with DLBC, AML, and BC. A total of 202 missense mutations, 17 truncating mutations, 7 fusions, and 3 in-frame mutations were identified. Further, 17 genes and 19 miRNAs were found to be exclusively co-expressed and echinoderm microtubule-associated protein-like 4 (EML4) was identified as the most positively correlated gene (log odds ratio >3). The gene ontology and signaling pathways of the genes co-expressed with ALK in these six cancers were also identified. Our findings offer a basis for ALK as a prognostic biomarker and therapeutic target in cancers, which will potentially contribute to precision oncology and assist clinicians in identifying suitable treatment options. ALK expression; Patient prognosis; LUAD; Co-expression; Cancers.
登录
查看更多内容
影响因子:
14.9
作者:
Ghoussaini M;Mountjoy E;Carmona M;Peat G;Schmidt EM;Hercules A;Fumis L;Miranda A;Carvalho-Silva D;Buniello A;Burdett T;Hayhurst J;Baker J;Ferrer J;Gonzalez-Uriarte A;Jupp S;Karim MA;Koscielny G;Machlitt-Northen S;Malangone C;Pendlington ZM;Roncaglia P;Suveges D;Wright D;Vrousgou O;Papa E;Parkinson H;MacArthur JAL;Todd JA;Barrett JC;Schwartzentruber J;Hulcoop DG;Ochoa D;McDonagh EM;Dunham I
通讯作者:
Dunham I
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
影响因子:
--
作者:
Hanna MG;Najfeld V;Irie HY;Tripodi J;Nayak A
通讯作者:
Nayak A
影响因子:
14.9
作者:
Kuleshov MV;Jones MR;Rouillard AD;Fernandez NF;Duan Q;Wang Z;Koplev S;Jenkins SL;Jagodnik KM;Lachmann A;McDermott MG;Monteiro CD;Gundersen GW;Ma'ayan A
通讯作者:
Ma'ayan A
影响因子:
5.7
作者:
Gritsina G;Xiao F;O'Brien SW;Gabbasov R;Maglaty MA;Xu RH;Thapa RJ;Zhou Y;Nicolas E;Litwin S;Balachandran S;Sigal LJ;Huszar D;Connolly DC
通讯作者:
Connolly DC